John LaCava

John LaCava

Auto-generated profile, based on publicly available information

John LaCava

European Research Institute for the Biology of Ageing, University Medical Center, Groningen, Netherlands

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in Cell
Verified
Journal Article
Closed access
JLJohn LaCava
John LaCava
JHJonathan Houseley
Jonathan Houseley
CSCosmin Saveanu
Cosmin Saveanu
EPElisabeth Petfalski
Elisabeth Petfalski
ETElizabeth Thompson
Elizabeth Thompson
DTDavid Tollervey
David Tollervey

1 July 2006 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
JHJonathan Houseley
Jonathan Houseley
JLJohn LaCava
John LaCava
DTDavid Tollervey
David Tollervey

1 November 2013 in Cell
Verified
Journal Article
Closed access
MTMartin Samuel Taylor
Martin Samuel Taylor
JLJohn LaCava
John LaCava
PMPaolo Mita
Paolo Mita
KMKelly R. Molloy
Kelly R. Molloy
CHCheng Ran Lisa Huang
Cheng Ran Lisa Huang
LDLixin Dai
Lixin Dai

24 November 2013 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
PAPeter Refsing Andersen
Peter Refsing Andersen
MDMichal Domanski
Michal Domanski
MKMaiken S Kristiansen
Maiken S Kristiansen
HSHelena Storvall
Helena Storvall
ENEvgenia Ntini
Evgenia Ntini
TJTorben Heick Jensen
Torben Heick Jensen
How the nuclear exosome is targeted to nuclear RNA substrates is poorly understood. An affinity-capture MS approach and functional analyses now demonstrate a physical and functional connection between the human exosome and the cap-binding complex (CBC). A CBC-containing complex was found to promote transcription termination of several RNA types, thus suggesting a direct link to exosomal RNA degradation. Nuclear processing and quality control of eukaryotic RNA is mediated by the RNA exosome, which is regulated by accessory factors. However, the mechanism of exosome recruitment to its ribonucleoprotein (RNP) targets remains poorly understood. Here we report a physical link between the human exosome and the cap-binding complex (CBC). The CBC associates with the ARS2 protein to form CBC–ARS2 (CBCA) and then further connects, together with the ZC3H18 protein, to the nuclear exosome targeting (NEXT) complex, thus forming CBC–NEXT (CBCN). RNA immunoprecipitation using CBCN factors as well as the analysis of combinatorial depletion of CBCN and exosome components underscore the functional relevance of CBC-exosome bridging at the level of target RNA. Specifically, CBCA suppresses read-through products of several RNA families by promoting their transcriptional termination. We suggest that the RNP 5′ cap links transcription termination to exosomal RNA degradation through CBCN.

14 December 2023 in Nature
Verified
Journal Article
Open access
PDF file
EBEric T. Baldwin
Eric T. Baldwin
TETrevor van Eeuwen
Trevor van Eeuwen
DHDavid Hoyos
David Hoyos
AZArthur Olegovich Zalevsky
Arthur Olegovich Zalevsky
ETEgor P. Tchesnokov
Egor P. Tchesnokov
MTMartin Samuel Taylor
Martin Samuel Taylor
The LINE-1 (L1) retrotransposon is an ancient genetic parasite that has written around one-third of the human genome through a ‘copy and paste’ mechanism catalysed by its multifunctional enzyme, open reading frame 2 protein (ORF2p)1. ORF2p reverse transcriptase (RT) and endonuclease activities have been implicated in the pathophysiology of cancer2,3, autoimmunity4,5 and ageing6,7, making ORF2p a potential therapeutic target. However, a lack of structural and mechanistic knowledge has hampered efforts to rationally exploit it. We report structures of the human ORF2p ‘core’ (residues 238–1061, including the RT domain) by X-ray crystallography and cryo-electron microscopy in several conformational states. Our analyses identified two previously undescribed folded domains, extensive contacts to RNA templates and associated adaptations that contribute to unique aspects of the L1 replication cycle. Computed integrative structural models of full-length ORF2p show a dynamic closed-ring conformation that appears to open during retrotransposition. We characterize ORF2p RT inhibition and reveal its underlying structural basis. Imaging and biochemistry show that non-canonical cytosolic ORF2p RT activity can produce RNA:DNA hybrids, activating innate immune signalling through cGAS/STING and resulting in interferon production6–8. In contrast to retroviral RTs, L1 RT is efficiently primed by short RNAs and hairpins, which probably explains cytosolic priming. Other biochemical activities including processivity, DNA-directed polymerization, non-templated base addition and template switching together allow us to propose a revised L1 insertion model. Finally, our evolutionary analysis demonstrates structural conservation between ORF2p and other RNA- and DNA-dependent polymerases. We therefore provide key mechanistic insights into L1 polymerization and insertion, shed light on the evolutionary history of L1 and enable rational drug development targeting L1.

8 January 2018 in eLife
Verified
Journal Article
Open access
PMPaolo Mita
Paolo Mita
AWAleksandra Wudzinska
Aleksandra Wudzinska
XSXiaoji Sun
Xiaoji Sun
JAJoshua Andrade
Joshua Andrade
SNShruti Nayak
Shruti Nayak
JBJef D Boeke
Jef D Boeke
LINE-1/L1 retrotransposon sequences comprise 17% of the human genome. Among the many classes of mobile genetic elements, L1 is the only autonomous retrotransposon that still drives human genomic plasticity today. Through its co-evolution with the human genome, L1 has intertwined itself with host cell biology. However, a clear understanding of L1’s lifecycle and the processes involved in restricting its insertion and intragenomic spread remains elusive. Here we identify modes of L1 proteins’ entrance into the nucleus, a necessary step for L1 proliferation. Using functional, biochemical, and imaging approaches, we also show a clear cell cycle bias for L1 retrotransposition that peaks during the S phase. Our observations provide a basis for novel interpretations about the nature of nuclear and cytoplasmic L1 ribonucleoproteins (RNPs) and the potential role of DNA replication in L1 retrotransposition.